Friedman Bart bought OVID
February 26, 2026 · Form 4 insider transaction
Friedman Bart bought 65,000 shares of Ovid Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
65,000
Price
$0.00
Total value
N/A
InsiderFriedman Bart
RoleDirector
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 26, 2026
Filing dateMarch 2, 2026
Shares owned after65,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option will vest in full on February 26, 2027, subject to the Reporting Person's continuous service through such vesting date.